Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of Dreem 3S to Evaluate Continuous Wake and Sleep Monitoring for the Diagnosis and Treatment Monitoring of Narcolepsy.

NCT06531876 is registered in ClinicalTrials.gov with Beacon Biosignals as lead sponsor.

NCT NCT06531876
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06531876 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of Dreem 3S to Evaluate Continuous Wake and Sleep Monitoring for the Diagnosis and Treatment Monitoring of Narcolepsy.
Lead sponsor
Beacon Biosignals
Phase
Observational
Overall status
Completed
Start date
July 1, 2024
Completion date
March 1, 2026
Enrollment
78 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

hypersomnia, narcolepsy type 1, sleep disorder